• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    New insight of vitamin D in chronic liver diseases

    2014-05-04 09:38:13EnQiangChenYingShiandHongTang

    En-Qiang Chen, Ying Shi and Hong Tang

    Chengdu, China

    New insight of vitamin D in chronic liver diseases

    En-Qiang Chen, Ying Shi and Hong Tang

    Chengdu, China

    BACKGROUND:Vitamin D is a fat-soluble sterol derivative that is predominantly synthesized in the liver and has multiple functions. The accumulative data showed that the clinical manifestations and prognosis of chronic liver diseases are associated with serum vitamin D levels.

    DATA SOURCES:A PubMed and Google Scholar search using terms: "vitamin D", "25(OH)D", "liver disease", "viral hepatitis", "non-alcoholic fatty liver disease", "liver fibrosis", "cirrhosis", "hepatocellular carcinoma" and "autoimmune liver disease" was performed, and relevant articles published in English between January 2000 and March 2014 were reviewed. Fulltext publications relevant to the field were selected and relevant articles from reference lists were also included.

    RESULTS:The insufficiency or deficiency of vitamin D is common in various kinds of chronic liver diseases including viral hepatitis B and C. Serum 25-hydroxyvitamin D and vitamin D receptors are possibly interrelated with the incidence, treatment and prognosis of diseases. Though the evidence of vitamin D supplementation in viral hepatitis and associated liver diseases is still limited, there is great potential to apply this adjuvant therapy to improve the treatments.

    CONCLUSIONS:Although the exact role and mechanisms of vitamin D have not been fully elucidated in chronic liver diseases, it is potentially beneficial in the treatment of chronic liver diseases. Further mechanistic studies are needed to validate its clinical application.

    (Hepatobiliary Pancreat Dis Int 2014;13:580-585)

    vitamin D;

    deficiency;

    viral hepatitis;

    chronic liver diseases

    Introduction

    Vitamin D, the sunshine vitamin, is now recognized not only for its importance of bone health in humans,[1]but also for other health benefits including reducing the risk or progression of chronic liver diseases (CLDs). Vitamin D produced in the skin or ingested in the diet is biologically inert and requires two successive hydroxylations first in the liver on carbon 25 to form 25-hydroxyvitamin D [25(OH)D], and then in the kidney for a hydroxylation on carbon 1 to form the most important biologically active form of vitamin D, 1, 25-dihydroxyvitamin D [1, 25(OH)2D].[2]It is worthy to mention that extra renal hydroxylation of 25(OH)D is also important for the non-skeletal actions of vitamin D, because 1, 25(OH)2D controls a variety of genes directly or indirectly to regulate cellular proliferation, differentiation, apoptosis and angiogenesis.[3]

    In the past decades, methods have been developed to measure serum 25(OH)D and 1, 25(OH)2D concentrationsin vivo. In recent years, lots of evidences suggest that serum 25(OH)D is the best indicator of vitamin D statusin vivo;[4]while serum 1, 25(OH)2D provides limited information about vitamin D status, because it is often normal or even elevated due to secondary hyperparathyroidism associated with vitamin D deficiency. So serum 25(OH)D examination now has been widely used to evaluate vitamin D concentrations in clinical practice.[4]

    Clinical and epidemiological data have shown that chronic viral hepatitis and their extrahepatic manifestations are associated with lower vitamin D concentrations.[5]In recent years, there has been considerable speculation about the potential role of vitamin D in the treatment of CLD patients with low serum vitamin D levels.[6,7]It is encouraging that the therapeutic value of vitamin D supplement has been confirmed in autoimmune liver diseases.[8,9]And a recent study[10]also showed the association between vitamin D shortage and the severity of chronic viral hepatitis, non-alcoholic fatty liver disease (NAFLD) and other CLDs. In this review, we briefly summarize thenew progress of factors affecting vitamin D deficiency in common CLDs and the correlation of viral hepatitis and other CLDs with reduced serum 25(OH)D concentrations.

    Factors associated with vitamin D deficiency

    Serum 25(OH)D concentration is an objective variable reflecting vitamin D restoration in body, but there is no exact definition of its normal range in real clinical setting. In general population, the normal concentration of serum 25(OH)D is 75-120 nmol/L (30-50 ng/mL), inadequate concentration is 50-75 nmol/L (20-30 ng/ mL), while shortage concentration is less than 50 nmol/ L (<20 ng/mL); and there is no difference between male and female populations. According to this standard, approximately one billion people worldwide are vitamin D inadequate or shortage.

    Most scholars believe that the lack of sun ultraviolet exposure is the main cause of vitamin D insufficiency, because air pollution induced by modern industry retard the necessary ultraviolet radiation which is essential for vitamin D synthesis.[11]Currently, modern lifestyle habits also play a pivotal role in vitamin D inadequate or shortage. To prevent skin aging or cancer, sun umbrella and sunscreen cosmetics are intentionally utilized to stay away from sunshine. The prolongation of life span is another factor of vitamin D deficiency, vitamin D synthesis in skin and absorption by intestinal tract declines along with increasing age.[11]Additionally, the vitamin D content in modern fortified foods is significantly less than that in wild oily marine fish, freshwater fish, cod liver oil, egg yolk and so on. In recent years, high heritability suggests that genetic factors could also play a role in vitamin D deficiency.[12,13]For example, variants genes involved in cholesterol synthesis, hydroxylation, and vitamin D transport affect vitamin D status; and genetic variation at these loci identifies individuals who have substantially raised risk of vitamin D insufficiency.[12]

    The distribution of the vitamin D in the body also affects the serum levels. Serum 25(OH)D is often decreased in obese people because of the retaining of vitamin D in adipose tissue. The vitamin D retaining capability of the adipose tissue is the same and therefore, the vitamin D is diluted in people with obese, leading to the decrease of serum vitamin D. The weight loss caused by malabsorption may also lower the serum vitamin D level. As there is no feedback regulation of hydroxylation of vitamin D in the liver, when liver parenchyma disease occurs, impaired hydroxylation of vitamin D can also lead to vitamin D deficiency or shortage.[14,15]A genetic study[12]showed that vitamin D related gene polymorphisms, including vitamin D-binding protein (DBP), vitamin D receptor (VDR) and α1 hydroxylase gene, are associated with serum vitamin D concentrations.

    Viral hepatitis

    Clinical evidence indicated that patients with chronic hepatitis C (CHC) are always at higher risk of vitamin D deficiency.[16]In a large scale study,[17]serum 25(OH)D in CHC patients was significantly lower than that in healthy population (25.07±9.92 vs 43.06±10.19 ng/mL, P<0.0001), and serum 25(OH)D was less than 30 ng/mL in 73% of CHC patients whereas only 6% in the healthy controls. Current evidence[17,18]suggested that HCV not only inhibits 25(OH)D synthesis by regulating lipid metabolism, but also decreases the production of previtamin D, which is an intermediate in the cascades of 1, 25(OH)2D synthesis.[19]Low serum 25(OH)D level is associated with the severity of liver diseases and fibrosis damage in CHC patients.[20,21]

    Serum 25(OH)D deficiency is associated with the severity of liver diseases in human immunodeficiency virus (HIV)/HCV co-infected patients,[10,22]and lower serum 25(OH)D may also impair virological response to pegylated interferon α (PEG-IFNα) and ribavirin (RBV) therapy in those HIV/HCV co-infected patients.[23]The low level of serum vitamin D may negatively affect the virological response of PEG-IFNα/ RBV, and appropriate vitamin D supplement would improve sustained virological response in CHC and HIV/ HCV co-infected patients.[22,23]Gal-Tanamy et al[24]suggested that vitamin D inhibits HCV RNA replication directly, possessing natural antiviral activity, and its collaborative antiviral effect with interferon improves antiviral effect in CHC patients.[6,25]Kondo et al[26]reported that 1, 25(OH)2D supplement improves the sensitivity of PEG-IFNα/RBV therapy on HCV-infected hepatocytes by reducing the IP-10 production from PBMCs and ISGs expression in the liver. Additionally, the beneficial effect of vitamin D on decreasing insulin resistance and improving systemic inflammation may also contribute to the virological response of PEGIFNα/RBV therapy in CHC patients.[6,27,28]These data indicate that CHC patients with low serum vitamin D need to supply this vitamin when they are treated with PEG-IFNα/RBV.[29]It is worthy to mention that serum DBP and the polymorphism of DBP are known to influence vitamin D levels; and in difficult-to-treat HCV genotypes, simultaneous pretreatment normal serum vitamin D levels and the carriage of DBP wild-type isoform strongly predicts the achievement of sustained virological response after PEG-IFNα/RBV antiviraltherapy.[30]

    New evidence continues to suggest a relationship between serum vitamin D level and chronic hepatitis B (CHB). Farnik et al[31]quantitatively examined the levels of serum 25(OH)D in 203 untreated CHB patients, and found that there were 34% patients with severe vitamin deficiency (<10 ng/mL), 47% with vitamin D insufficiency, and only 19% with normal level. Whereas vitamin D level in HBeAg positive patients is notably lower than that in HBeAg negative patients. Meanwhile, vitamin D level presents opposite seasonal fluctuations compared with HBV DNA, and the low level of serum 25(OH)D is correlated with high HBV DNA.[31]Though, it is still uncertain whether the low level of serum vitamin D decreases the efficacy of PEG- IFNα or nucleos(t)ide analogs, some scholars speculated that appropriate vitamin D supplement may be helpful to improve or optimize curative efficacy of existing antiviral therapy for CHB patients with vitamin D deficiency. Because of the huge amount of CHB patients all over the world and the relative limited therapeutic drugs and antiviral strategies, it is very important and necessary to recognize the role of vitamin D in CHB progression, and potential value for increasing the antiviral efficacy of existing antiviral therapy and developing new targets for antiviral treatment in the future.

    NAFLD

    The morbidity of NAFLD is on the rise worldwide, and epidemiological data showed that NAFLD morbidity is significantly higher in the vitamin D deficiency population than that in normal subjects; similarly, NAFLD patients tend to have a lower vitamin D level.[32-34]

    Nakano and coworkers[35]reported that in an animal study the lower level of vitamin D is associated with obesity and severity of liver steatosis, indicating that vitamin D deficiency may participate in NAFLD progression. Vitamin D deficiency may also up-regulate hepatic inflammation and oxidative stress genes via endotoxin and Toll-like receptor pathway to cause NAFLD.[36]Considering the significance of insulin resistance in NAFLD development,[37]the correlation between vitamin D deficiency and insulin resistance might be another important cause of the progression of NAFLD, as low vitamin D level is associated with the impaired function of islet beta cells.[38]Interestingly, current preclinical studies demonstrated that sunlight exposure and vitamin D supplements helped to ameliorate NAFLD histopathology. Kitson and Roberts[39]proposed that vitamin D plays an important role in the activation and regulation of both innate and adaptive immune systems, which indicate the beneficial effect of vitamin D on NAFLD. Although the exact mechanism is still not clear, we believe that vitamin D is an effective drug in the prevention and treatment of NAFLD.

    Liver fibrosis and cirrhosis

    Due to the severe liver functional damage, the construction of transport proteins in patients with fibrosis and cirrhosis is decreased. Thus, vitamin D de ficiency is very common in these patients. In HIV/ HCV co-infected patients, serum 25(OH)D levels are signi ficantly correlated with the Metavir fibrosis score; and patients with severe fibrosis (Metavir F3/F4) have lower serum 25(OH)D levels compared with F2 and F1 patients (16.2 ± 10.0 vs 18.9±8.5 and 20.9±11.1 ng/ mL, respectively).[22]In genotype I CHC patients, lower serum vitamin D levels are signi ficantly associated with the severity of liver fibrosis,[17]and correction of vitamin D de ficiency in patients with CLD is a potential therapy to inhibit progression of fibrosis, as 1, 25(OH)2D and its nuclear receptor repress human α1(I) collagen expression and type I collagen formation.[40]Indeed, those clinical findings are also supported by in vitro and in vivo experiments, showing that 1, 25(OH)2D possesses antifibrosis effect both in bone marrow mesenchymal stem cells and fibrosis rat, with the increasing expression of VDR caused by 1, 25(OH)2D, which inhibit the proliferation of hepatic stellate cells and the expression of cyclin D1, tissue inhibitor of metalloproteinase 1 and collagen.[41]In addition, vitamin D is also able to reduce the production of body smooth muscle actin and collagen, thus inhibiting the progression of liver cirrhosis induced by thioacetamide. All those clues strongly suggest that vitamin D is most likely to be an anti-fibrosis agent.[42]

    In the past years, genome-wide studies have identified genetic variants (including DHCR7, CYP2R1 and DBP) that affect serum 25(OH)D levels in healthy populations; and GG homozygosis for DHCR7 gene and lower 25(OH)D levels in CHC patients are both independently associated with the severity of liver fibrosis.[43]Grünhage et al[44]also reported that the common variation in 25(OH)D metabolism is associated with liver stiffness in patients with CLD, and the stronger influence of 25(OH)D is on the initiation rather than progression of hepatic fibrosis. Moreover, the low level of VDR is also an important factor affecting fibrosis,[45]and VDR gene polymorphism is significantly linked with fibrosis and cirrhosis progression,[46]including the presence of cirrhosis in CHC patients.[21]

    Hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is the sixth mostcommon cancer in the world, approximately 630 000 new cases are diagnosed each year. Amany them, 82% of the cases are related to viral hepatitis, 55% to HBV; but 89% of the cases are in regions where HBV is endemic.[47]

    There is a correlation between the progressive decline of active vitamin D and the progression of liver disease. Genetic analyses also revealed a role for vitamin D insufficiency in HCV-associated HCC development.[48]Thus, some researchers[49]proposed that serum vitamin D is also a potential biomarker of HCC, just like serum α-fetoprotein, and that vitamin D may be valuable for monitoring HCC in patients with high-risk, including those with CHB or CHC. In addition, vitamin D deficiency is common in HCC patients after liver transplantation and is closely related to prognosis, thus serum vitamin D levels also may be a prognostic indicator for HCC after treatment, and vitamin D supplementation may help to prevent acute cellular rejection in liver recipients with severe vitamin D deficiency.

    Though current epidemiological data are not enough to completely uncover the correlation between vitamin D and HCC, lots of experimental evidences suggested that vitamin D and its analogs (such as EB1089 and seocalcitol) have inhibitory effect against HCC cell lines.[50-52]Active 1, 25(OH)2D has anti-tumor effects in several aspects, including anti-proliferation, antiinflammatory, anti-angiogenesis, promoting apoptosis and differentiation.[51,53,54]Moreover, DBP-macrophage activating factor activates macrophages, the latter has anti-angiogenic activity and tumor killing activity, which inhibit HCC growth.[55]All of the data above implied that vitamin D and vitamin D-related molecules may represent a new strategy for the treatment of HCC.

    Autoimmune liver disease

    The development of autoimmune disease is based on the interaction of genetic susceptibility and environmental causes. Vitamin D endocrine system plays important roles in host immune system responses. For example, activated macrophages (a type of immune cell) not only produce 1, 25(OH)2D, but also express VDR.[56]And the liverproduced 1, 25(OH)2D could further activate a negative feed-back loop at sites of inflammation and therefore contribute to the suppression of the occurrence of autoimmune liver disease.[56]

    Actually, the active vitamin D acts its biological effects by binding to its own receptor VDR; and vitamin D also modulates the expression of VDR in human bile duct epithelial cells. D'Aldebert et al[57]demonstrated that biliary epithelial cells in human liver expressed both cathelicidin and VDR, and that VDR is also an important nuclear receptor for ursodeoxycholic acid (UDCA) inducing cathelicidin expression in biliary epithelial cells. Thus the hepatic expression of VDR increased the efficacy of UDCA therapy, and vitamin D and UDCA have synergistic effect on some autoimmune liver diseases such as primary biliary cirrhosis and primary sclerosing cholangitis.

    Recent studies[58,59]found that genetic factors appear to be involved in the pathogenesis of autoimmune liver diseases, and that VDR polymorphisms may be associated with autoimmune liver diseases such as autoimmune hepatitis and primary biliary cirrhosis. However, further studies are still needed to elucidate the mechanisms by which VDR polymorphisms contribute to the losing of immune tolerance in autoimmune diseases.

    Summary

    Vitamin D, along with its related VDR, is possibly interrelated with the incidence, treatment and prognosis of a variety of chronic liver diseases. Though the exact role and mechanisms of vitamin D in viral hepatitis have not been fully elucidated and the evidence for vitamin D supplement in those populations is still limited, vitamin D supplement may potentially optimize the current treatment. The role of vitamin D in CLD needs further study.

    Contributors:TH proposed the study. CEQ and SY performed research and wrote the first draft. CEQ collected and analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. TH is the guarantor.

    Funding:This study was supported by grants from the National Twelve-Five Project of China (2012ZX10002007-001-003), and the Chinese Foundation for Hepatitis Prevention and Control-TianQing Liver Disease Research Fund (cfhpc20132047).

    Ethical approval:Not needed.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol 2013;5:51-108.

    2 Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011;12:4-18.

    3 Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662-687.

    4 Health Quality Ontario. Clinical utility of vitamin d testing: an evidence-based analysis. Ont Health Technol Assess Ser 2010;10:1-93.

    5 Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010;55:2624-2628.

    6 Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011;24:43-50.

    7 Han YP, Kong M, Zheng S, Ren Y, Zhu L, Shi H, et al. Vitamin D in liver diseases: from mechanisms to clinical trials. J Gastroenterol Hepatol 2013;28:49-55.

    8 Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-1688S.

    9 Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol 2013;37:535-545.

    10 Guzmán-Fulgencio M, García-álvarez M, Berenguer J, Jiménez-Sousa Má, Cosín J, Pineda-Tenor D, et al. Vitamin D deficiency is associated with severity of liver disease in HIV/ HCV coinfected patients. J Infect 2014;68:176-184.

    11 Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol 2011;91:115-124.

    12 Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180-188.

    13 Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-2745.

    14 Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013;33:338-352.

    15 Nair S. Vitamin d deficiency and liver disease. Gastroenterol Hepatol (N Y) 2010;6:491-493.

    17 Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010;51:1158-1167.

    18 Clark PJ, Thompson AJ, Vock DM, Kratz LE, Tolun AA, Muir AJ, et al. Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology 2012;56:49-56.

    19 Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006;92:17-25.

    20 El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol 2012;4:242-247.

    21 Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, et al. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635-643.

    22 Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011;55:756-761.

    23 Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, et al. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS 2013;27:227-232.

    24 Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, et al. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011;54:1570-1579.

    25 Petta S, Ferraro D, Cammà C, Cabibi D, Di Cristina A, Di Marco V, et al. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther 2012;17:823-831.

    26 Kondo Y, Kato T, Kimura O, Iwata T, Ninomiya M, Kakazu E, et al. 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. PLoS One 2013;8:e63672.

    27 Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-na?ve patients. World J Gastroenterol 2011;17:5184-5190.

    28 Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 na?ve patients. World J Gastroenterol 2012;18:800-805.

    29 Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol 2013;58:184-189.

    30 Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, et al. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012;56:1641-1650.

    30 Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology 2013;58:1270-1276.

    32 Targher G, Scorletti E, Mantovani A, Byrne CD. Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. Metab Syndr Relat Disord 2013;11:217-228.

    33 Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38:246-254.

    34 Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2013;23:792-798.

    35 Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011;55:415-425.

    36 Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 2012;55:1103-1111.

    37 Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010;16:1941-1951.

    38 Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes2011;60:2947-2953.

    39 Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol 2012;57:897-909.

    40 Potter JJ, Liu X, Koteish A, Mezey E. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int 2013;33: 677-686.

    41 Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011;60:1728-1737.

    42 Song BJ, Rockey DC. Status of research on vitamin D supplementation in treating or preventing liver fibrosis. Liver Int 2013;33:653-655.

    43 Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, et al. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat 2013;20:486-493.

    44 Grünhage F, Hochrath K, Krawczyk M, H?blinger A, Obermayer-Pietsch B, Geisel J, et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012;56:1883-1891.

    45 Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013;153:601-613.

    46 Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol 2009;50:1202-1209.

    47 Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg 2011;74:4-8.

    48 Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, et al. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS One 2013;8:e64053.

    49 Hammad LN, Abdelraouf SM, Hassanein FS, Mohamed WA, Schaalan MF. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? J Immunotoxicol 2013;10:380-386.

    50 Ghous Z, Akhter J, Pourgholami MH, Morris DL. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study. Anticancer Res 2008;28:3757-3761.

    51 Chiang KC, Yeh CN, Chen MF, Chen TC. Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol 2011;26:1597-1603.

    52 Dalhoff K, Dancey J, Astrup L, Skovsgaard T, Hamberg KJ, Lofts FJ, et al. A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer 2003;89:252-257.

    53 Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X, et al. 1, 25(OH)2D3inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr Med Chem 2013;20:4131-4141.

    54 Fingas CD, Altinbas A, Schlattjan M, Beilfuss A, Sowa JP, Sydor S, et al. Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma. Digestion 2013;87:176-181.

    55 Nonaka K, Onizuka S, Ishibashi H, Uto Y, Hori H, Nakayama T, et al. Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice. J Surg Res 2012;172:116-122.

    56 Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49:277-300.

    57 D'Aldebert E, Biyeyeme Bi Mve MJ, Mergey M, Wendum D, Firrincieli D, Coilly A, et al. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 2009;136: 1435-1443.

    58 Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002;35:126-131.

    59 Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005;20:249-255.

    Received March 27, 2014

    Accepted after revision June 30, 2014

    Author Affiliations: Center of Infectious Diseases, West China Hospital; and Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China (Chen EQ, Shi Y and Tang H)

    Hong Tang, MD, PhD, Center of Infectious Diseases, West China Hospital; and Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China (Tel: +86-28-85422650; Fax: +86-28-85423052; Email: htang6198@hotmail. com)

    ? 2014, Hepatobiliary Pancreat Dis Int. All rights reserved.

    10.1016/S1499-3872(14)60295-2

    Published online August 21, 2014.

    国产熟女欧美一区二区| 99热全是精品| 亚洲精品一区蜜桃| 成人高潮视频无遮挡免费网站| 男女边摸边吃奶| 日本wwww免费看| 99九九线精品视频在线观看视频| 在线免费观看不下载黄p国产| 又黄又爽又刺激的免费视频.| av福利片在线观看| 精品国产三级普通话版| 美女xxoo啪啪120秒动态图| 精品一区二区三区视频在线| 国产欧美日韩精品一区二区| 成年美女黄网站色视频大全免费 | 综合色丁香网| 国产精品爽爽va在线观看网站| 观看美女的网站| 97热精品久久久久久| 美女内射精品一级片tv| 久久久国产一区二区| 精品一区二区免费观看| 精品久久久久久电影网| 最黄视频免费看| 欧美日韩精品成人综合77777| 少妇人妻一区二区三区视频| 日韩av不卡免费在线播放| 免费观看在线日韩| 人人妻人人澡人人爽人人夜夜| 五月开心婷婷网| 欧美激情国产日韩精品一区| av福利片在线观看| 亚洲国产av新网站| 亚洲国产最新在线播放| 国产免费又黄又爽又色| 91午夜精品亚洲一区二区三区| 2018国产大陆天天弄谢| 国产乱来视频区| 午夜免费男女啪啪视频观看| 久久精品人妻少妇| 高清av免费在线| 女性被躁到高潮视频| 国产亚洲av片在线观看秒播厂| 国产探花极品一区二区| 婷婷色麻豆天堂久久| av一本久久久久| 高清欧美精品videossex| 97精品久久久久久久久久精品| 精品久久久噜噜| 夜夜看夜夜爽夜夜摸| 最黄视频免费看| 高清不卡的av网站| 亚洲精品乱码久久久v下载方式| 少妇高潮的动态图| 高清日韩中文字幕在线| 熟女人妻精品中文字幕| 亚洲性久久影院| 国产精品成人在线| 欧美zozozo另类| 啦啦啦啦在线视频资源| 国产精品一二三区在线看| 免费av不卡在线播放| 国产熟女欧美一区二区| 国产亚洲午夜精品一区二区久久| 精品久久久久久久末码| 欧美高清性xxxxhd video| 黄色日韩在线| av免费在线看不卡| 国产 精品1| av专区在线播放| 男人舔奶头视频| 国产亚洲最大av| 99热这里只有是精品在线观看| 97超碰精品成人国产| 国产精品福利在线免费观看| 成人漫画全彩无遮挡| 99热这里只有是精品在线观看| 麻豆成人av视频| 欧美日韩视频精品一区| 啦啦啦视频在线资源免费观看| 香蕉精品网在线| 久久鲁丝午夜福利片| 久久精品久久久久久噜噜老黄| 毛片一级片免费看久久久久| 中文字幕久久专区| 国产黄频视频在线观看| 天天躁日日操中文字幕| 久久精品熟女亚洲av麻豆精品| 亚洲av欧美aⅴ国产| 精品久久国产蜜桃| 久久99热6这里只有精品| 亚洲国产精品999| 亚洲精品,欧美精品| 观看美女的网站| 国产欧美日韩一区二区三区在线 | 涩涩av久久男人的天堂| 欧美区成人在线视频| 色吧在线观看| 青青草视频在线视频观看| 综合色丁香网| 欧美人与善性xxx| 网址你懂的国产日韩在线| 1000部很黄的大片| 一级二级三级毛片免费看| 成年免费大片在线观看| 久久女婷五月综合色啪小说| 2018国产大陆天天弄谢| 亚洲成人一二三区av| 国产在线视频一区二区| 色吧在线观看| 久久人人爽人人片av| 色5月婷婷丁香| 五月伊人婷婷丁香| 美女cb高潮喷水在线观看| 成年女人在线观看亚洲视频| 久久国产乱子免费精品| 一区二区三区乱码不卡18| 一级爰片在线观看| 国产一区二区三区av在线| 啦啦啦中文免费视频观看日本| 熟妇人妻不卡中文字幕| 国产免费一级a男人的天堂| 一级毛片电影观看| 国产欧美日韩一区二区三区在线 | 涩涩av久久男人的天堂| 久久精品人妻少妇| 国精品久久久久久国模美| 亚洲人成网站在线播| 欧美最新免费一区二区三区| 久久久国产一区二区| 国产中年淑女户外野战色| 熟女av电影| 观看av在线不卡| 亚洲成人手机| 99久久精品一区二区三区| 亚洲av国产av综合av卡| 精品久久久久久久末码| 国产精品人妻久久久久久| 国产真实伦视频高清在线观看| 毛片一级片免费看久久久久| 欧美变态另类bdsm刘玥| 亚洲美女视频黄频| 国产成人aa在线观看| 久久久久久久久久成人| 免费不卡的大黄色大毛片视频在线观看| 麻豆成人午夜福利视频| 日本黄色日本黄色录像| 欧美精品国产亚洲| 久热久热在线精品观看| 国产高潮美女av| 舔av片在线| 晚上一个人看的免费电影| 夫妻性生交免费视频一级片| 国产精品免费大片| 美女高潮的动态| .国产精品久久| 777米奇影视久久| 日本黄色片子视频| 免费观看在线日韩| av在线播放精品| 免费黄频网站在线观看国产| 欧美精品一区二区免费开放| 高清欧美精品videossex| 欧美高清成人免费视频www| 99热国产这里只有精品6| 我要看黄色一级片免费的| 久热这里只有精品99| 国产一区二区三区av在线| 一级毛片我不卡| 亚洲丝袜综合中文字幕| 又大又黄又爽视频免费| 乱系列少妇在线播放| 亚洲最大成人中文| 多毛熟女@视频| 欧美极品一区二区三区四区| 男女啪啪激烈高潮av片| 91精品伊人久久大香线蕉| 免费少妇av软件| 街头女战士在线观看网站| 欧美成人a在线观看| 大又大粗又爽又黄少妇毛片口| 蜜臀久久99精品久久宅男| 高清不卡的av网站| 97超碰精品成人国产| 特大巨黑吊av在线直播| 岛国毛片在线播放| 黑人猛操日本美女一级片| 纯流量卡能插随身wifi吗| 制服丝袜香蕉在线| 国产综合精华液| av在线app专区| av网站免费在线观看视频| 黄色怎么调成土黄色| 亚洲国产毛片av蜜桃av| 日韩精品有码人妻一区| 秋霞在线观看毛片| 久久人妻熟女aⅴ| 我要看日韩黄色一级片| av女优亚洲男人天堂| 免费观看无遮挡的男女| 亚洲av男天堂| 日本欧美国产在线视频| 国产一区二区三区综合在线观看 | 精品亚洲成a人片在线观看 | 国产乱人偷精品视频| 日韩人妻高清精品专区| 亚洲综合精品二区| 九草在线视频观看| 国产精品免费大片| 国产在线一区二区三区精| 精品人妻偷拍中文字幕| 婷婷色综合www| 欧美老熟妇乱子伦牲交| 国产精品一及| 国产视频内射| 1000部很黄的大片| 18禁裸乳无遮挡免费网站照片| 18+在线观看网站| 亚洲怡红院男人天堂| 乱系列少妇在线播放| h日本视频在线播放| 国产精品三级大全| tube8黄色片| 亚洲熟女精品中文字幕| 51国产日韩欧美| 亚洲经典国产精华液单| 欧美日韩视频高清一区二区三区二| 涩涩av久久男人的天堂| 中文欧美无线码| 99久久精品国产国产毛片| 人妻一区二区av| 黑人高潮一二区| 国产精品久久久久久久久免| 亚洲精品久久久久久婷婷小说| 王馨瑶露胸无遮挡在线观看| 人妻制服诱惑在线中文字幕| 国产高清国产精品国产三级 | 国产高清国产精品国产三级 | 欧美一区二区亚洲| 男女无遮挡免费网站观看| 日韩中字成人| 性色av一级| 日本免费在线观看一区| 精品久久久久久久末码| 伦精品一区二区三区| 3wmmmm亚洲av在线观看| 国产精品人妻久久久影院| 成人亚洲精品一区在线观看 | 又大又黄又爽视频免费| 777米奇影视久久| 国语对白做爰xxxⅹ性视频网站| 内地一区二区视频在线| 十八禁网站网址无遮挡 | 久久国产乱子免费精品| 天堂8中文在线网| 99热6这里只有精品| 免费看不卡的av| 久久精品人妻少妇| 有码 亚洲区| 国产精品熟女久久久久浪| 少妇的逼水好多| 婷婷色综合大香蕉| 国产视频内射| 两个人的视频大全免费| 一本久久精品| 大陆偷拍与自拍| 精品少妇久久久久久888优播| 一级毛片aaaaaa免费看小| 日本vs欧美在线观看视频 | 免费大片黄手机在线观看| 伦理电影免费视频| 国产欧美日韩精品一区二区| 久久人人爽人人爽人人片va| 国产日韩欧美亚洲二区| 久久久成人免费电影| 男人狂女人下面高潮的视频| 国产亚洲5aaaaa淫片| 国产精品熟女久久久久浪| 一个人看的www免费观看视频| 丰满迷人的少妇在线观看| 一级爰片在线观看| 一本—道久久a久久精品蜜桃钙片| 国产v大片淫在线免费观看| 亚洲一区二区三区欧美精品| 亚洲国产精品成人久久小说| 成人毛片60女人毛片免费| 亚洲国产最新在线播放| 成人亚洲精品一区在线观看 | 国产精品人妻久久久久久| 亚洲av福利一区| 99热这里只有精品一区| 免费观看a级毛片全部| 一级黄片播放器| 肉色欧美久久久久久久蜜桃| 在线观看免费高清a一片| 欧美激情国产日韩精品一区| 国产综合精华液| 久久久精品免费免费高清| 色吧在线观看| 最近最新中文字幕大全电影3| 黄片wwwwww| 韩国高清视频一区二区三区| 午夜日本视频在线| 亚洲国产色片| 亚洲av欧美aⅴ国产| 国产亚洲精品久久久com| 看十八女毛片水多多多| 亚洲aⅴ乱码一区二区在线播放| 尾随美女入室| 舔av片在线| 99久久精品一区二区三区| 亚洲精品色激情综合| av在线app专区| 少妇人妻 视频| 干丝袜人妻中文字幕| 亚洲精品亚洲一区二区| 最近2019中文字幕mv第一页| 久久热精品热| 久久精品夜色国产| 午夜福利高清视频| 国产成人aa在线观看| av在线蜜桃| 99久久精品国产国产毛片| 成人亚洲欧美一区二区av| 日日摸夜夜添夜夜爱| 久久av网站| 久久久久人妻精品一区果冻| 亚洲无线观看免费| 18禁在线播放成人免费| 亚洲,欧美,日韩| 激情五月婷婷亚洲| 国产在线男女| a级毛片免费高清观看在线播放| 联通29元200g的流量卡| 日韩三级伦理在线观看| 一级爰片在线观看| 国产亚洲欧美精品永久| 日韩一区二区视频免费看| 国产成人精品婷婷| 夜夜爽夜夜爽视频| 一级a做视频免费观看| 欧美97在线视频| 一个人看的www免费观看视频| 激情五月婷婷亚洲| 日韩视频在线欧美| 中文精品一卡2卡3卡4更新| 国产大屁股一区二区在线视频| 精品久久久久久电影网| 国产 一区 欧美 日韩| 亚洲av.av天堂| 国产久久久一区二区三区| 国内揄拍国产精品人妻在线| 女的被弄到高潮叫床怎么办| 在线看a的网站| 爱豆传媒免费全集在线观看| 欧美日韩视频精品一区| 欧美成人一区二区免费高清观看| 又黄又爽又刺激的免费视频.| 男女边摸边吃奶| 日日摸夜夜添夜夜爱| 亚洲国产毛片av蜜桃av| 国产一区二区三区av在线| 一区二区三区免费毛片| 国产日韩欧美在线精品| 国产黄频视频在线观看| 王馨瑶露胸无遮挡在线观看| 国产日韩欧美在线精品| 亚洲美女黄色视频免费看| 91精品伊人久久大香线蕉| 青春草视频在线免费观看| 免费高清在线观看视频在线观看| 欧美xxxx黑人xx丫x性爽| 一级爰片在线观看| 一本—道久久a久久精品蜜桃钙片| 国产亚洲av片在线观看秒播厂| 丰满人妻一区二区三区视频av| 欧美 日韩 精品 国产| 五月伊人婷婷丁香| 亚洲精品一区蜜桃| av又黄又爽大尺度在线免费看| 国产免费又黄又爽又色| 成人特级av手机在线观看| 午夜免费男女啪啪视频观看| 成人漫画全彩无遮挡| 高清视频免费观看一区二区| 校园人妻丝袜中文字幕| 色综合色国产| 一本久久精品| 三级国产精品欧美在线观看| 欧美精品亚洲一区二区| 国产精品成人在线| 蜜桃久久精品国产亚洲av| 日韩制服骚丝袜av| 老熟女久久久| 欧美精品一区二区免费开放| 深爱激情五月婷婷| 日本爱情动作片www.在线观看| 九九爱精品视频在线观看| 久久久午夜欧美精品| 一区二区三区四区激情视频| 80岁老熟妇乱子伦牲交| 亚洲伊人久久精品综合| 简卡轻食公司| 最近中文字幕2019免费版| 久久人人爽人人爽人人片va| 狠狠精品人妻久久久久久综合| 国产精品国产三级专区第一集| 日韩一区二区三区影片| 最黄视频免费看| 国产久久久一区二区三区| 亚洲综合色惰| 久久国产精品男人的天堂亚洲 | 美女福利国产在线 | 亚洲色图综合在线观看| 亚洲图色成人| 国产免费一级a男人的天堂| av女优亚洲男人天堂| 亚洲精品视频女| 久久久久性生活片| 日韩中字成人| 国产大屁股一区二区在线视频| 国产欧美另类精品又又久久亚洲欧美| 成年女人在线观看亚洲视频| av一本久久久久| 欧美人与善性xxx| 亚洲,一卡二卡三卡| 国产精品一区二区三区四区免费观看| 精品久久久精品久久久| av在线蜜桃| 少妇熟女欧美另类| 观看av在线不卡| 伊人久久国产一区二区| 亚洲内射少妇av| 欧美老熟妇乱子伦牲交| 在线观看免费高清a一片| 国产有黄有色有爽视频| 下体分泌物呈黄色| 亚洲欧美日韩无卡精品| 亚洲av在线观看美女高潮| 国产精品人妻久久久影院| 人妻 亚洲 视频| 国产精品一区二区在线不卡| 国产探花极品一区二区| 精品久久久精品久久久| 日韩av不卡免费在线播放| 欧美丝袜亚洲另类| 又大又黄又爽视频免费| 久久国产精品男人的天堂亚洲 | 色综合色国产| 国产亚洲精品久久久com| 久久久亚洲精品成人影院| 久久99热6这里只有精品| 3wmmmm亚洲av在线观看| 国产高清三级在线| 国产精品一区二区在线不卡| 看十八女毛片水多多多| 男人爽女人下面视频在线观看| 蜜臀久久99精品久久宅男| 在线亚洲精品国产二区图片欧美 | 少妇被粗大猛烈的视频| 国产色爽女视频免费观看| 97在线视频观看| 十八禁网站网址无遮挡 | 国产色爽女视频免费观看| 男女边吃奶边做爰视频| 成人高潮视频无遮挡免费网站| 一区二区三区乱码不卡18| 成人毛片a级毛片在线播放| 99热全是精品| 日本wwww免费看| 大又大粗又爽又黄少妇毛片口| 成人18禁高潮啪啪吃奶动态图 | 国国产精品蜜臀av免费| 中文精品一卡2卡3卡4更新| 精品99又大又爽又粗少妇毛片| 成人黄色视频免费在线看| 国产 精品1| 午夜福利在线观看免费完整高清在| 久久久色成人| 边亲边吃奶的免费视频| 午夜老司机福利剧场| 国产在线视频一区二区| 啦啦啦中文免费视频观看日本| 日韩国内少妇激情av| 日韩成人av中文字幕在线观看| 欧美变态另类bdsm刘玥| 一级片'在线观看视频| 天堂俺去俺来也www色官网| 国产黄色免费在线视频| av女优亚洲男人天堂| av在线蜜桃| 高清欧美精品videossex| 熟女电影av网| 午夜老司机福利剧场| .国产精品久久| 好男人视频免费观看在线| 国产黄片美女视频| av卡一久久| h日本视频在线播放| 毛片一级片免费看久久久久| 性高湖久久久久久久久免费观看| 亚洲欧美日韩卡通动漫| 岛国毛片在线播放| 久久国产亚洲av麻豆专区| 国产欧美亚洲国产| 最近中文字幕高清免费大全6| 不卡视频在线观看欧美| 人人妻人人添人人爽欧美一区卜 | 日日摸夜夜添夜夜爱| 永久网站在线| 男人狂女人下面高潮的视频| 爱豆传媒免费全集在线观看| 亚洲,欧美,日韩| 日本一二三区视频观看| 亚洲精品自拍成人| 99久久人妻综合| 多毛熟女@视频| 性高湖久久久久久久久免费观看| a 毛片基地| 精品久久久久久久久亚洲| 国产一区有黄有色的免费视频| 成人18禁高潮啪啪吃奶动态图 | 国产一级毛片在线| 在线观看av片永久免费下载| 少妇 在线观看| 精品国产三级普通话版| 欧美变态另类bdsm刘玥| 六月丁香七月| 男女边摸边吃奶| 特大巨黑吊av在线直播| 国产男人的电影天堂91| 内射极品少妇av片p| 热99国产精品久久久久久7| 亚洲熟女精品中文字幕| 成人综合一区亚洲| 国精品久久久久久国模美| 日韩欧美 国产精品| 干丝袜人妻中文字幕| 各种免费的搞黄视频| 伦精品一区二区三区| 大香蕉97超碰在线| 观看av在线不卡| 成年女人在线观看亚洲视频| 美女福利国产在线 | 午夜福利影视在线免费观看| 一区二区三区精品91| 中文字幕人妻熟人妻熟丝袜美| 亚洲精品国产成人久久av| 国产男女超爽视频在线观看| 三级国产精品片| 久久久成人免费电影| 免费看不卡的av| 午夜福利影视在线免费观看| 深夜a级毛片| 日韩视频在线欧美| 卡戴珊不雅视频在线播放| 男的添女的下面高潮视频| 中文字幕制服av| 欧美另类一区| 黑丝袜美女国产一区| 秋霞在线观看毛片| 一本色道久久久久久精品综合| 99国产精品免费福利视频| 久久久久网色| 少妇丰满av| 日韩欧美一区视频在线观看 | 97在线人人人人妻| 久久久久视频综合| 欧美一区二区亚洲| 一级二级三级毛片免费看| 赤兔流量卡办理| 伦理电影免费视频| 国产精品不卡视频一区二区| 一二三四中文在线观看免费高清| 久久久久久久久久人人人人人人| 久久久久网色| 亚洲精品亚洲一区二区| 免费在线观看成人毛片| 久久精品久久久久久噜噜老黄| 亚洲精品中文字幕在线视频 | 国产精品国产av在线观看| 尾随美女入室| 在线观看国产h片| 中文字幕久久专区| 97在线视频观看| 亚洲最大成人中文| 日韩免费高清中文字幕av| 日韩欧美 国产精品| 欧美成人a在线观看| 麻豆乱淫一区二区| 国产精品偷伦视频观看了| 国产精品伦人一区二区| 成人国产麻豆网| 免费黄网站久久成人精品| 久久久久视频综合| 国产av一区二区精品久久 | 国产精品嫩草影院av在线观看| 亚洲一区二区三区欧美精品| 欧美 日韩 精品 国产| 七月丁香在线播放| 人妻 亚洲 视频| 国产高清有码在线观看视频| 美女脱内裤让男人舔精品视频| av女优亚洲男人天堂| 91久久精品电影网| 天堂俺去俺来也www色官网| 搡女人真爽免费视频火全软件| 中文字幕久久专区| 欧美日韩视频高清一区二区三区二| av天堂中文字幕网| 乱系列少妇在线播放| 五月伊人婷婷丁香| 国产精品麻豆人妻色哟哟久久| 久久ye,这里只有精品| 亚洲av二区三区四区|